Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Armata Pharmaceuticals, Inc.APHB · Entity 6329 | Director | September 07, 2017 | September 12, 2017 |
| Fresh Tracks Therapeutics, Inc.BBI · Entity 90076 | Director | May 17, 2022 | May 17, 2022 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Armata Pharmaceuticals, Inc.
Report date September 07, 2017 · Filed September 12, 2017
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (Right to Buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.91 · Expires 2027-09-06 | Direct | 10,900 |
Reported balance
After 2017-09-07 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2017-09-07 · Grant · Acquired 10,900 · Balance 10,900 |
Fresh Tracks Therapeutics, Inc.
Report date May 17, 2022 · Filed May 17, 2022
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Stock Option (right to buy)SEC Table II · derivative / convertible security · Conversion / exercise price $0.19 · Expires 2032-05-17 | Direct | 65,000 |
Reported balance
After 2022-05-17 transaction · row 1
Instrument identity requires review; Table II rows are not merged.
1 source rowRow 1 · 2022-05-17 · Grant · Acquired 65,000 · Balance 65,000 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 17, 2022 Filed May 17, 2022 17:16 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | GrantStock Option (right to buy) · Derivative | 65,000 | $0.00 Strike: $0.19 | $0.00 |
DisclosureSEC source: 0000819050-22-000073 · wf-form4_165282211444816.xml · derivative · entry 1 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 65,000 Underlying: Common Stock · 65,000 shares Expires 2032-05-17 Read SEC document |
| June 14, 2021 Filed Jun 14, 2021 16:44 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | GrantStock Option (right to buy) · Derivative | 40,000 | $0.00 Strike: $0.90 | $0.00 |
DisclosureSEC source: 0000819050-21-000087 · wf-form4_162370346407607.xml · derivative · entry 1 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 40,000 Underlying: Common Stock · 40,000 shares Expires 2031-06-14 Read SEC document |
| December 31, 2020 Filed Jan 5, 2021 18:30 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Tax withholdingCommon Stock | 4,408 | $0.78 | $3,438.24 |
DisclosureSEC source: 0001062993-21-000138 · form4.xml · nonDerivative · entry 1 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,134 F1 · shares: Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 17:07 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | GrantStock Option (right to buy) · Derivative | 60,000 | $0.00 Strike: $0.80 | $0.00 |
DisclosureSEC source: 0001062993-20-004557 · form4.xml · derivative · entry 2 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,000 Underlying: Common Stock · 60,000 shares Expires 2030-09-15 F2 · derivative.exercise_date: The stock options will vest 25% on September 15, 2021, and the remainder will vest in equal monthly installments over the following three years. Read SEC document |
| September 15, 2020 Filed Sep 17, 2020 17:07 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | GrantCommon Stock | 10,493 | $0.81 | $8,499.33 |
DisclosureSEC source: 0001062993-20-004557 · form4.xml · nonDerivative · entry 1 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,542 F1 · shares: On September 15, 2020, the reporting person was granted 10,493 restricted stock units ("RSUs") in lieu of a portion of cash compensation as a director of Brickell Biotech, Inc. The RSUs are scheduled to vest on December 31, 2020 and will be settled in the form of one share of common stock for each RSU. F1 · price: On September 15, 2020, the reporting person was granted 10,493 restricted stock units ("RSUs") in lieu of a portion of cash compensation as a director of Brickell Biotech, Inc. The RSUs are scheduled to vest on December 31, 2020 and will be settled in the form of one share of common stock for each RSU. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 16:23 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Exercise / conversionRestricted Stock Units · Derivative | 609 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-20-004309 · form4.xml · derivative · entry 4 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 609 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") converted into common stock on a one-for-one basis. F3 · derivative.exercise_date: These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020. F3 · derivative.expiration_date: These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 16:23 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Tax withholdingCommon Stock | 6,375 | $0.94 | $5,992.50 |
DisclosureSEC source: 0001062993-20-004309 · form4.xml · nonDerivative · entry 3 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,049 F2 · shares: Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 16:23 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Tax withholdingCommon Stock | 256 | $0.94 | $240.64 |
DisclosureSEC source: 0001062993-20-004309 · form4.xml · nonDerivative · entry 2 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,424 F2 · shares: Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs. Read SEC document |
| August 31, 2020 Filed Sep 2, 2020 16:23 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Exercise / conversionCommon Stock | 609 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-20-004309 · form4.xml · nonDerivative · entry 1 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,680 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") converted into common stock on a one-for-one basis. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 16:42 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Exercise / conversionRestricted Stock Units · Derivative | 608 | $0.00 | $0.00 |
DisclosureSEC source: 0001062993-20-003643 · form4.xml · derivative · entry 3 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 609 Underlying: Common Stock · 608 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") converted into common stock on a one-for-one basis. F3 · derivative.exercise_date: These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020. F3 · derivative.expiration_date: These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 16:42 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Tax withholdingCommon Stock | 256 | $0.92 | $235.52 |
DisclosureSEC source: 0001062993-20-003643 · form4.xml · nonDerivative · entry 2 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,071 F2 · shares: Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs. Read SEC document |
| July 31, 2020 Filed Aug 4, 2020 16:42 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Exercise / conversionCommon Stock | 608 | Not disclosed | Not disclosed |
DisclosureSEC source: 0001062993-20-003643 · form4.xml · nonDerivative · entry 1 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,327 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") converted into common stock on a one-for-one basis. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 14:02 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Exercise / conversionRestricted Stock Units · Derivative | 608 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000145 · edgar.xml · derivative · entry 3 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,217 Underlying: Common Stock · 608 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") converted into common stock on a one-for-one basis. F3 · derivative.exercise_date: These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020. F3 · derivative.expiration_date: These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020. F4 · balance_after: The reporting person filed a Form 4 on June 5, 2020 which reported, among other transactions, the vesting on various dates of portions of a grant of RSUs made to the reporting person on February 14, 2020. Column 9 of Table II of that Form 4 incorrectly reported the number of unvested RSUs remaining from that grant following each such vesting. The number reported in this Column 9 of Table II of this Form 4 represents the correct number of unvested RSUs remaining from the February 14, 2020 grant following the vestings that were reported on the Form 4 filed on June 5, 2020, as well as the vesting that occurred on June 30, 2020 as reported on this Form 4. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 14:02 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Tax withholdingCommon Stock | 256 | $1.00 | $256.00 |
DisclosureSEC source: 0000911916-20-000145 · edgar.xml · nonDerivative · entry 2 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,719 F2 · shares: Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs. Read SEC document |
| June 30, 2020 Filed Jul 2, 2020 14:02 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Exercise / conversionCommon Stock | 608 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000911916-20-000145 · edgar.xml · nonDerivative · entry 1 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,975 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") converted into common stock on a one-for-one basis. Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 17:29 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | GrantStock Option (right to buy) · Derivative | 4,333 | $0.00 Strike: $1.12 | $0.00 |
DisclosureSEC source: 0000911916-20-000122 · edgar.xml · derivative · entry 17 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,333 Underlying: Common Stock · 4,333 shares Expires 2030-06-03 Read SEC document |
| June 03, 2020 Filed Jun 5, 2020 17:29 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | GrantCommon Stock | 15,178 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000122 · edgar.xml · nonDerivative · entry 11 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 18,367 F3 · shares: Represents RSUs that are scheduled to vest on August 31, 2020 and will be settled in the form of one share of common stock for each RSU. Read SEC document |
| May 31, 2020 Filed Jun 5, 2020 17:29 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Exercise / conversionRestricted Stock Units · Derivative | 608 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000122 · edgar.xml · derivative · entry 16 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 608 Underlying: Common Stock · 608 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") converted into common stock on a one-for-one basis. F4 · derivative.exercise_date: These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020. F4 · derivative.expiration_date: These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020. Read SEC document |
| May 31, 2020 Filed Jun 5, 2020 17:29 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Tax withholdingCommon Stock | 256 | $1.16 | $296.96 |
DisclosureSEC source: 0000911916-20-000122 · edgar.xml · nonDerivative · entry 10 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,189 F2 · shares: Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs. Read SEC document |
| May 31, 2020 Filed Jun 5, 2020 17:29 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Exercise / conversionCommon Stock | 608 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000911916-20-000122 · edgar.xml · nonDerivative · entry 9 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,445 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") converted into common stock on a one-for-one basis. Read SEC document |
| April 30, 2020 Filed Jun 5, 2020 17:29 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Exercise / conversionRestricted Stock Units · Derivative | 609 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000122 · edgar.xml · derivative · entry 15 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 609 Underlying: Common Stock · 609 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") converted into common stock on a one-for-one basis. F4 · derivative.exercise_date: These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020. F4 · derivative.expiration_date: These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020. Read SEC document |
| April 30, 2020 Filed Jun 5, 2020 17:29 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Tax withholdingCommon Stock | 256 | $1.20 | $307.20 |
DisclosureSEC source: 0000911916-20-000122 · edgar.xml · nonDerivative · entry 8 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,837 F2 · shares: Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs. Read SEC document |
| April 30, 2020 Filed Jun 5, 2020 17:29 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Exercise / conversionCommon Stock | 609 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000911916-20-000122 · edgar.xml · nonDerivative · entry 7 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,093 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") converted into common stock on a one-for-one basis. Read SEC document |
| March 31, 2020 Filed Jun 5, 2020 17:29 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Exercise / conversionRestricted Stock Units · Derivative | 608 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000122 · edgar.xml · derivative · entry 14 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 608 Underlying: Common Stock · 608 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") converted into common stock on a one-for-one basis. F4 · derivative.exercise_date: These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020. F4 · derivative.expiration_date: These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020. Read SEC document |
| March 31, 2020 Filed Jun 5, 2020 17:29 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Tax withholdingCommon Stock | 256 | $1.19 | $304.64 |
DisclosureSEC source: 0000911916-20-000122 · edgar.xml · nonDerivative · entry 6 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,484 F2 · shares: Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs. Read SEC document |
| March 31, 2020 Filed Jun 5, 2020 17:29 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Exercise / conversionCommon Stock | 608 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000911916-20-000122 · edgar.xml · nonDerivative · entry 5 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,740 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") converted into common stock on a one-for-one basis. Read SEC document |
| February 29, 2020 Filed Jun 5, 2020 17:29 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Exercise / conversionRestricted Stock Units · Derivative | 608 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000122 · edgar.xml · derivative · entry 13 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 608 Underlying: Common Stock · 608 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") converted into common stock on a one-for-one basis. F4 · derivative.exercise_date: These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020. F4 · derivative.expiration_date: These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020. Read SEC document |
| February 29, 2020 Filed Jun 5, 2020 17:29 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Tax withholdingCommon Stock | 256 | $2.93 | $750.08 |
DisclosureSEC source: 0000911916-20-000122 · edgar.xml · nonDerivative · entry 4 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,132 F2 · shares: Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs. Read SEC document |
| February 29, 2020 Filed Jun 5, 2020 17:29 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Exercise / conversionCommon Stock | 608 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000911916-20-000122 · edgar.xml · nonDerivative · entry 3 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,388 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") converted into common stock on a one-for-one basis. Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 17:06 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | GrantStock Options · Derivative | 7,328 | $1.16 Strike: $1.16 | $8,500.48 |
DisclosureSEC source: 0001214659-20-001605 · marketforms-47813.xml · derivative · entry 3 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,328 Underlying: Common Stock · 7,328 shares Expires 2030-02-13 Read SEC document |
| February 14, 2020 Filed Feb 19, 2020 17:06 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | GrantRestricted Stock Units · Derivative | 2,167 | $1.16 Strike: $1.16 | $2,513.72 |
DisclosureSEC source: 0001214659-20-001605 · marketforms-47813.xml · derivative · entry 2 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,167 Underlying: Common Stock · 2,167 shares Expires 2030-02-13 Read SEC document |
| February 14, 2020 Filed Jun 5, 2020 17:36 UTC Amendment | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | GrantStock Options · Derivative | 2,167 | $0.00 Strike: $1.16 | $0.00 |
DisclosureSEC source: 0000911916-20-000126 · edgar.xml · derivative · entry 2 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,167 Underlying: Common Stock · 2,167 shares Expires 2030-02-13 F1 · security: The Form 4 filed on February 19, 2020 inadvertently switched the number of restricted stock units and stock options granted. This amendment is being filed to reflect the correct numbers granted. Read SEC document |
| February 14, 2020 Filed Jun 5, 2020 17:36 UTC Amendment | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | GrantRestricted Stock Units · Derivative | 7,328 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000126 · edgar.xml · derivative · entry 1 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,328 Underlying: Common Stock · 7,328 shares Expires not disclosed F1 · security: The Form 4 filed on February 19, 2020 inadvertently switched the number of restricted stock units and stock options granted. This amendment is being filed to reflect the correct numbers granted. F2 · derivative.exercise_price: Restricted stock units ("RSUs") convert into common stock on a one-for-one basis. F3 · derivative.exercise_date: These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020. F3 · derivative.expiration_date: These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020. Read SEC document |
| February 14, 2020 Filed Jun 5, 2020 17:29 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Exercise / conversionRestricted Stock Units · Derivative | 3,070 | $0.00 | $0.00 |
DisclosureSEC source: 0000911916-20-000122 · edgar.xml · derivative · entry 12 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,070 Underlying: Common Stock · 3,070 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: Restricted stock units ("RSUs") converted into common stock on a one-for-one basis. F4 · derivative.exercise_date: These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020. F4 · derivative.expiration_date: These RSUs were granted on February 14, 2020 and vest in installments through August 31, 2020. Read SEC document |
| February 14, 2020 Filed Jun 5, 2020 17:29 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Tax withholdingCommon Stock | 1,290 | $1.16 | $1,496.40 |
DisclosureSEC source: 0000911916-20-000122 · edgar.xml · nonDerivative · entry 2 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,780 F2 · shares: Represents shares withheld to satisfy tax withholding obligations upon the vesting of RSUs. Read SEC document |
| February 14, 2020 Filed Jun 5, 2020 17:29 UTC | Fresh Tracks Therapeutics, Inc. BBI · Entity 90076 | Exercise / conversionCommon Stock | 3,070 | Not disclosed | Not disclosed |
DisclosureSEC source: 0000911916-20-000122 · edgar.xml · nonDerivative · entry 1 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,070 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · price: Restricted stock units ("RSUs") converted into common stock on a one-for-one basis. Read SEC document |
| June 18, 2018 Filed Jun 19, 2018 12:47 UTC | Fresh Tracks Therapeutics, Inc. VICL · Entity 90076 | GrantNonstatutory Stock Option (right to buy) · Derivative | 105,000 | $0.00 Strike: $1.81 | $0.00 |
DisclosureSEC source: 0001209191-18-038465 · doc4.xml · derivative · entry 1 SAMANT VIJAY B · CIK 0001198238 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 105,000 Underlying: Common Stock · 105,000 shares Expires 2028-01-07 F1 · shares: On January 8, 2018, the reporting person was granted an option to purchase 105,000 shares of common stock, with vesting tied to performance-based objectives. The performance criteria have been met, resulting in vesting of the option as to 105,000 shares. Read SEC document |
| January 08, 2018 Filed Jan 10, 2018 11:36 UTC | Fresh Tracks Therapeutics, Inc. VICL · Entity 90076 | GrantNonstatutory Stock Option (right to buy) · Derivative | 36,775 | $0.00 Strike: $1.81 | $0.00 |
DisclosureSEC source: 0001209191-18-003071 · doc4.xml · derivative · entry 2 SAMANT VIJAY B · CIK 0001198238 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 36,775 Underlying: Common Stock · 36,775 shares Expires 2028-01-07 F1 · derivative.exercise_date: The right to exercise the above stock option generally vests one-fourth on the first anniversary of the grant, with the remaining rights vesting quarterly over the remaining three years. Read SEC document |
| January 08, 2018 Filed Jan 10, 2018 11:36 UTC | Fresh Tracks Therapeutics, Inc. VICL · Entity 90076 | GrantEmployee Stock Option (right to buy) · Derivative | 68,225 | $0.00 Strike: $1.81 | $0.00 |
DisclosureSEC source: 0001209191-18-003071 · doc4.xml · derivative · entry 1 SAMANT VIJAY B · CIK 0001198238 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 68,225 Underlying: Common Stock · 68,225 shares Expires 2028-01-07 F1 · derivative.exercise_date: The right to exercise the above stock option generally vests one-fourth on the first anniversary of the grant, with the remaining rights vesting quarterly over the remaining three years. Read SEC document |
| September 07, 2017 Filed Sep 12, 2017 21:57 UTC | Armata Pharmaceuticals, Inc. APHB · Entity 6329 | GrantStock Option (Right to Buy) · Derivative | 10,900 | $0.00 Strike: $0.91 | $0.00 |
DisclosureSEC source: 0001209191-17-052469 · doc4.xml · derivative · entry 1 SAMANT VIJAY B · CIK 0001198238 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,900 Underlying: Common Stock · 10,900 shares Expires 2027-09-06 Read SEC document |
| May 25, 2017 Filed May 30, 2017 17:20 UTC | Fresh Tracks Therapeutics, Inc. VICL · Entity 90076 | GrantNonstatutory Stock Option (right to buy) · Derivative | 25,000 | $0.00 Strike: $2.31 | $0.00 |
DisclosureSEC source: 0001209191-17-036177 · doc4.xml · derivative · entry 1 SAMANT VIJAY B · CIK 0001198238 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,000 Underlying: Common Stock · 25,000 shares Expires 2027-01-11 F1 · shares: On January 12, 2017, the reporting person was granted an option to purchase 25,000 shares of common stock, with vesting tied to performance-based objectives. The performance criteria have been met, resulting in vesting of the option as to 25,000 shares. Read SEC document |
| February 01, 2017 Filed Feb 3, 2017 16:16 UTC | Fresh Tracks Therapeutics, Inc. VICL · Entity 90076 | SaleCommon Stock $.01 par value | 3,750 | $2.16 | $8,088.38 |
DisclosureSEC source: 0001209191-17-007584 · doc4.xml · nonDerivative · entry 1 SAMANT VIJAY B · CIK 0001198238 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 87,420 F1 · kind: Sale of 3,750 shares of common stock to cover withholding taxes on restricted stock units released. The sale was affected by a broker pursuant to instructions set forth in a Rule 10b5-1 plan adopted by the Reporting Person and delivered to the broker on June 13, 2016. F2 · price: Represents a weighted average sales price per share. The prices actually received ranged from $2.10 to $2.19. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F3 · balance_after: This balance includes 15,000 unvested shares subject to restricted stock units. Read SEC document |
| January 12, 2017 Filed Jan 17, 2017 14:15 UTC | Fresh Tracks Therapeutics, Inc. VICL · Entity 90076 | GrantNonstatutory Stock Option (right to buy) · Derivative | 80,000 | $0.00 Strike: $2.31 | $0.00 |
DisclosureSEC source: 0001209191-17-003836 · doc4.xml · derivative · entry 3 SAMANT VIJAY B · CIK 0001198238 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 80,000 Underlying: Common Stock · 80,000 shares Expires 2027-01-11 F2 · derivative.exercise_date: The right to exercise the above stock option generally vests one-half on the first anniversary of the grant, with the remaining rights vesting on the second anniversary of the grant date. Read SEC document |
| January 12, 2017 Filed Jan 17, 2017 14:15 UTC | Fresh Tracks Therapeutics, Inc. VICL · Entity 90076 | GrantNonstatutory Stock Option (right to buy) · Derivative | 21,854 | $0.00 Strike: $2.31 | $0.00 |
DisclosureSEC source: 0001209191-17-003836 · doc4.xml · derivative · entry 2 SAMANT VIJAY B · CIK 0001198238 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,000 Underlying: Common Stock · 21,854 shares Expires 2027-01-11 F1 · derivative.exercise_date: The right to exercise the above stock option generally vests one-fourth on the first anniversary of the grant, with the remaining rights vesting quarterly over the remaining three years. Read SEC document |
| January 12, 2017 Filed Jan 17, 2017 14:15 UTC | Fresh Tracks Therapeutics, Inc. VICL · Entity 90076 | GrantEmployee Stock Option (right to buy) · Derivative | 28,146 | $0.00 Strike: $2.31 | $0.00 |
DisclosureSEC source: 0001209191-17-003836 · doc4.xml · derivative · entry 1 SAMANT VIJAY B · CIK 0001198238 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,146 Underlying: Common Stock · 28,146 shares Expires 2027-01-11 F1 · derivative.exercise_date: The right to exercise the above stock option generally vests one-fourth on the first anniversary of the grant, with the remaining rights vesting quarterly over the remaining three years. Read SEC document |
| January 10, 2017 Filed Jan 12, 2017 16:24 UTC | Fresh Tracks Therapeutics, Inc. VICL · Entity 90076 | SaleCommon Stock $.01 par value | 5,763 | $2.45 | $14,114.16 |
DisclosureSEC source: 0001209191-17-003505 · doc4.xml · nonDerivative · entry 1 SAMANT VIJAY B · CIK 0001198238 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 91,170 F1 · kind: Sale of 5,763 shares of common stock to cover withholding taxes on restricted stock units released. The sale was affected by a broker pursuant to instructions set forth in a Rule 10b5-1 plan adopted by the Reporting Person and delivered to the broker on June 13, 2016. F2 · price: Represents a weighted average sales price per share. The prices actually received ranged from $2.39 to $2.69. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F3 · balance_after: This balance includes 16,875 unvested shares subject to restricted stock units. Read SEC document |
| December 13, 2016 Filed Dec 13, 2016 18:45 UTC | Fresh Tracks Therapeutics, Inc. VICL · Entity 90076 | SaleCommon Stock $.01 par value | 4,649 | $2.40 | $11,172.48 |
DisclosureSEC source: 0001209191-16-155021 · doc4.xml · nonDerivative · entry 2 SAMANT VIJAY B · CIK 0001198238 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 96,933 F3 · price: Represents a weighted average price per share. The prices actually ranged from $2.39 to $2.43. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. Read SEC document |
| December 12, 2016 Filed Dec 13, 2016 18:45 UTC | Fresh Tracks Therapeutics, Inc. VICL · Entity 90076 | SaleCommon Stock $.01 par value | 11,050 | $2.39 | $26,415.03 |
DisclosureSEC source: 0001209191-16-155021 · doc4.xml · nonDerivative · entry 1 SAMANT VIJAY B · CIK 0001198238 · Director · President & CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 101,582 F1 · price: Represents a weighted average price per share. The prices actually ranged from $2.37 to $2.43. The Reporting Person has provided to the issuer, and will provide to any security holder of the issuer or the SEC staff, upon request, information regarding the number of shares sold at each price within the range. F2 · balance_after: Share amounts have been adjusted to give effect to a 1-for-10 reverse stock split on May 26, 2016. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.